BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 16943535)

  • 1. Risk of cardiovascular mortality in prostate cancer patients in the Rotterdam randomized screening trial.
    Otto SJ; Schröder FH; de Koning HJ
    J Clin Oncol; 2006 Sep; 24(25):4184-9. PubMed ID: 16943535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low all-cause mortality in the volunteer-based Rotterdam section of the European randomised study of screening for prostate cancer: self-selection bias?
    Otto SJ; Schröder FH; de Koning HJ
    J Med Screen; 2004; 11(2):89-92. PubMed ID: 15153324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immediate risk of suicide and cardiovascular death after a prostate cancer diagnosis: cohort study in the United States.
    Fang F; Keating NL; Mucci LA; Adami HO; Stampfer MJ; Valdimarsdóttir U; Fall K
    J Natl Cancer Inst; 2010 Mar; 102(5):307-14. PubMed ID: 20124521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
    Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
    Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Androgen deprivation therapy for localized prostate cancer and the risk of cardiovascular mortality.
    Tsai HK; D'Amico AV; Sadetsky N; Chen MH; Carroll PR
    J Natl Cancer Inst; 2007 Oct; 99(20):1516-24. PubMed ID: 17925537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cause-specific mortality in long-term survivors of breast cancer: A 25-year follow-up study.
    Hooning MJ; Aleman BM; van Rosmalen AJ; Kuenen MA; Klijn JG; van Leeuwen FE
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1081-91. PubMed ID: 16446057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary causes of death after permanent prostate brachytherapy.
    Bittner N; Merrick GS; Galbreath RW; Butler WM; Wallner KE; Allen ZA; Brammer SG; Moyad M
    Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):433-40. PubMed ID: 18448268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Prostate cancer Intervention Versus Observation Trial:VA/NCI/AHRQ Cooperative Studies Program #407 (PIVOT): design and baseline results of a randomized controlled trial comparing radical prostatectomy to watchful waiting for men with clinically localized prostate cancer.
    Wilt TJ; Brawer MK; Barry MJ; Jones KM; Kwon Y; Gingrich JR; Aronson WJ; Nsouli I; Iyer P; Cartagena R; Snider G; Roehrborn C; Fox S
    Contemp Clin Trials; 2009 Jan; 30(1):81-7. PubMed ID: 18783735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short- and long-term mortality with localized prostate cancer.
    Merglen A; Schmidlin F; Fioretta G; Verkooijen HM; Rapiti E; Zanetti R; Miralbell R; Bouchardy C
    Arch Intern Med; 2007 Oct; 167(18):1944-50. PubMed ID: 17923593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer.
    van den Belt-Dusebout AW; de Wit R; Gietema JA; Horenblas S; Louwman MW; Ribot JG; Hoekstra HJ; Ouwens GM; Aleman BM; van Leeuwen FE
    J Clin Oncol; 2007 Oct; 25(28):4370-8. PubMed ID: 17906202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absolute and relative risk of cardiovascular disease in men with prostate cancer: results from the Population-Based PCBaSe Sweden.
    Van Hemelrijck M; Garmo H; Holmberg L; Ingelsson E; Bratt O; Bill-Axelson A; Lambe M; Stattin P; Adolfsson J
    J Clin Oncol; 2010 Jul; 28(21):3448-56. PubMed ID: 20567006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased non-prostate cancer death risk in clinically diagnosed prostate cancer.
    van Leeuwen PJ; Otto SJ; Kranse R; Roobol MJ; Bul M; Zhu X; de Koning H; Schröder FH
    BJU Int; 2012 Jul; 110(2):188-94. PubMed ID: 22288823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interval cancers in prostate cancer screening: comparing 2- and 4-year screening intervals in the European Randomized Study of Screening for Prostate Cancer, Gothenburg and Rotterdam.
    Roobol MJ; Grenabo A; Schröder FH; Hugosson J
    J Natl Cancer Inst; 2007 Sep; 99(17):1296-303. PubMed ID: 17728218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies.
    Aviña-Zubieta JA; Choi HK; Sadatsafavi M; Etminan M; Esdaile JM; Lacaille D
    Arthritis Rheum; 2008 Dec; 59(12):1690-7. PubMed ID: 19035419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer detection and cancer characteristics in the European Randomized Study of Screening for Prostate Cancer (ERSPC)--Section Rotterdam. A comparison of two rounds of screening.
    Postma R; Schröder FH; van Leenders GJ; Hoedemaeker RF; Vis AN; Roobol MJ; van der Kwast TH
    Eur Urol; 2007 Jul; 52(1):89-97. PubMed ID: 17257742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The 20-Yr outcome in patients with well- or moderately differentiated clinically localized prostate cancer diagnosed in the pre-PSA era: the prognostic value of tumour ploidy and comorbidity.
    Adolfsson J; Tribukait B; Levitt S
    Eur Urol; 2007 Oct; 52(4):1028-35. PubMed ID: 17467883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Death in patients with recurrent prostate cancer after radical prostatectomy: prostate-specific antigen doubling time subgroups and their associated contributions to all-cause mortality.
    Freedland SJ; Humphreys EB; Mangold LA; Eisenberger M; Dorey FJ; Walsh PC; Partin AW
    J Clin Oncol; 2007 May; 25(13):1765-71. PubMed ID: 17470867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiation therapy for prostate cancer increases subsequent risk of bladder and rectal cancer: a population based cohort study.
    Nieder AM; Porter MP; Soloway MS
    J Urol; 2008 Nov; 180(5):2005-9; discussion 2009-10. PubMed ID: 18801517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erectile dysfunction prospectively associated with cardiovascular disease in the Dutch general population: results from the Krimpen Study.
    Schouten BW; Bohnen AM; Bosch JL; Bernsen RM; Deckers JW; Dohle GR; Thomas S
    Int J Impot Res; 2008; 20(1):92-9. PubMed ID: 17728804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term risk of cardiovascular disease in 5-year survivors of testicular cancer.
    van den Belt-Dusebout AW; Nuver J; de Wit R; Gietema JA; ten Bokkel Huinink WW; Rodrigus PT; Schimmel EC; Aleman BM; van Leeuwen FE
    J Clin Oncol; 2006 Jan; 24(3):467-75. PubMed ID: 16421423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.